Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder
- PMID: 20921976
- DOI: 10.1139/y10-072
Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder
Abstract
Hyperosmolar factors induce the neurogenic inflammatory response, leading to bladder overactivity (OAB). The aim of the study was to compare the bladder motor activity in a hyperosmolar and acute cyclophosphamide (CYP)-induced model of OAB. Furthermore, we set our sights on defining the most physiological model of OAB in experimental practice. Forty-two female rats were divided randomly into 5 groups. All animals underwent cystometry with the usage of isotonic saline or saline of increasing concentration. Acute chemical cystitis was induced by CYP to elicit OAB. The following cystometric parameters were analyzed: basal pressure, threshold pressure, micturition voiding pressure, intercontraction interval, compliance, functional bladder capacity, motility index, and detrusor overactivity index. CYP and hypertonic saline solutions induced OAB. Having been compared with CYP OAB, none of the rats infused with hypertonic solution exhibited macroscopic signs of bladder inflammation. The comparison of CYP and hyperosmolar models of OAB revealed that the greatest similarity existed between the 2080 mOsm/L OAB model and the acute CYP-induced model. We postulate that the 2080 mOsm/L model of OAB can be established as being a less invasive and more physiological model when compared with the CYP-induced OAB model. Additionally, it may also be a more reliable experimental tool for evaluating novel therapeutics for OAB as compared with CYP-induced models.
Similar articles
-
Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats.J Physiol Pharmacol. 2009 Dec;60(4):85-91. J Physiol Pharmacol. 2009. PMID: 20065501
-
Functional, histological structure and mastocytes alterations in rat urinary bladders following acute and [corrected] chronic cyclophosphamide treatment.J Physiol Pharmacol. 2010 Aug;61(4):477-82. J Physiol Pharmacol. 2010. PMID: 20814076
-
Animal models of overactive bladder: cyclophosphamide (CYP)-induced cystitis in rats.Folia Med Cracov. 2007;48(1-4):113-23. Folia Med Cracov. 2007. PMID: 19051698
-
Animal models in overactive bladder research.Handb Exp Pharmacol. 2011;(202):15-43. doi: 10.1007/978-3-642-16499-6_2. Handb Exp Pharmacol. 2011. PMID: 21290220 Review.
-
Pelvic organ prolapse and overactive bladder.Neurourol Urodyn. 2010;29(1):30-9. doi: 10.1002/nau.20858. Neurourol Urodyn. 2010. PMID: 20025017 Review.
Cited by
-
The effect of hyperosmolar stimuli and cyclophosphamide on the culture of normal rat urothelial cells in vitro.Cell Mol Biol Lett. 2012 Jun;17(2):196-205. doi: 10.2478/s11658-012-0002-y. Cell Mol Biol Lett. 2012. PMID: 22287017 Free PMC article.
-
Increased urothelial paracellular transport promotes cystitis.Am J Physiol Renal Physiol. 2015 Dec 15;309(12):F1070-81. doi: 10.1152/ajprenal.00200.2015. Epub 2015 Sep 30. Am J Physiol Renal Physiol. 2015. PMID: 26423859 Free PMC article.
-
Purinergic signalling in the urinary tract in health and disease.Purinergic Signal. 2014 Mar;10(1):103-55. doi: 10.1007/s11302-013-9395-y. Epub 2013 Nov 22. Purinergic Signal. 2014. PMID: 24265069 Free PMC article. Review.
-
A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors.Molecules. 2020 Mar 18;25(6):1384. doi: 10.3390/molecules25061384. Molecules. 2020. PMID: 32197469 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical